Natixis’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $75.1M | Buy |
|
|||||
|
2025
Q2 | $42.2M | Buy |
|
|||||
|
2025
Q1 | $29.5M | Sell |
|
|||||
|
2024
Q4 | $25M | Sell |
|
|||||
|
2024
Q3 | $33.7M | Buy |
|
|||||
|
2024
Q2 | $22.7M | Buy |
|
|||||
|
2024
Q1 | $11.2M | Buy |
|
|||||
|
2023
Q4 | $8.77M | Sell |
|
|||||
|
2023
Q3 | $26.6M | Sell |
|
|||||
|
2023
Q2 | $46.6M | Sell |
|
|||||
|
2023
Q1 | $55.6M | Buy |
|
|||||
|
2022
Q4 | $43.8M | Sell |
|
|||||
|
2022
Q3 | $65.5M | Buy |
|
|||||
|
2022
Q2 | $52.2M | Sell |
|
|||||
|
2022
Q1 | $134M | Buy |
|
|||||
|
2021
Q4 | $29.1M | Buy |
|
|||||
|
2021
Q3 | $16.4M | Sell |
|
|||||
|
2021
Q2 | $103M | Buy |
|
|||||
|
2021
Q1 | $67.3M | Sell |
|
|||||
|
2020
Q4 | $77.6M | Buy |
|
|||||
|
2020
Q3 | $59.8M | Buy |
|
|||||
|
2020
Q2 | $23.8M | Buy |
|
|||||
|
2020
Q1 | $1.67M | Sell |
|
|||||
|
2019
Q4 | $125M | Buy |
|
|||||
|
2019
Q3 | $48.6M | Buy |
|
|||||
|
2019
Q2 | $24.8M | Sell |
|
|||||
|
2019
Q1 | $30.2M | Sell |
|
|||||
|
2018
Q4 | $40.5M | Sell |
|
|||||
|
2018
Q3 | $218M | Buy |
|
|||||
|
2018
Q2 | $136M | Buy |
|
|||||
|
2018
Q1 | $3.1M | Sell |
|
|||||
|
2017
Q4 | $22.7M | Sell |
|
|||||
|
2017
Q3 | $189M | Buy |
|
|||||
|
2017
Q2 | $52.3M | Buy |
|
|||||
|
2017
Q1 | $17.8M | Buy |
|
|||||
|
2016
Q4 | $7.21M | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $1.57M | Sell |
|
|||||
|
2016
Q1 | $39.6M | Sell |
|
|||||
|
2015
Q4 | $57.7M | Buy |
|
|||||
|
2015
Q3 | $54.4M | Buy |
|